Please Wait
Applying Filters...
menu
    • menu
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Doxepin Hydrochloride

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 226Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    JB Chemicals gets USFDA nod to market generic medication
    JB Chemicals gets USFDA nod to market generic medication

    23 Aug 2023

    // ECONOMIC TIMES

    https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/jb-chemicals-gets-usfda-nod-to-market-generic-medication/articleshow/102981670.cms?utm_source=contentofinterest&utm_medium=text&utm_campaign=cppst

    ECONOMIC TIMES
    23 Aug 2023
    Share Share
    Unique Pharm's Generic Doxepin Hydrochloride Receives Approval in the U.S.
    Unique Pharm's Generic Doxepin Hydrochloride Receives Approval in the U.S.

    21 Aug 2023

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217975

    FDA
    21 Aug 2023
    Share Share
    Zydus Pharms' Generic Doxepin Hydrochloride Receives Approval in the U.S.
    Zydus Pharms' Generic Doxepin Hydrochloride Receives Approval in the U.S.

    16 Aug 2023

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202761

    FDA
    16 Aug 2023
    Share Share
    Amneal's Generic Doxepin Hydrochloride Receives Approval in U.S.
    Amneal's Generic Doxepin Hydrochloride Receives Approval in U.S.

    16 Aug 2023

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212357

    FDA
    16 Aug 2023
    Share Share
    Edenbridge Pharma's Generic Doxepin Hydrochloride Receives Approval in the U.S.
    Edenbridge Pharma's Generic Doxepin Hydrochloride Receives Approval in the U.S.

    19 Apr 2022

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213796

    FDA
    19 Apr 2022
    Share Share
    Jubilant Cadista's Generic Doxepin Hydrochloride Receives Approval in the U.S.
    Jubilant Cadista's Generic Doxepin Hydrochloride Receives Approval in the U.S.

    14 Mar 2022

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215483

    FDA
    14 Mar 2022
    Share Share